Clozapine re-challenge under the cover of Filgrastim
Rechallenge with clozapine, despite a history of clozapine-induced neutropenia is considered in patients with a good response to the drug in the past, for whom no other treatments are effective, and in cases where the risks of withholding treatment are greater than the risks of rechallenge. Dyscrasi...
Main Authors: | R Gopalakrishnan, T P Subhalakshmi, A Kuruvilla, K S Jacob |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Journal of Postgraduate Medicine |
Subjects: | |
Online Access: | http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2013;volume=59;issue=1;spage=54;epage=55;aulast=Gopalakrishnan |
Similar Items
-
Late onset clozapine induced agranulocytosis
by: Rajmohan Velayudhan, et al.
Published: (2014-01-01) -
Biosimilars in the management of neutropenia: focus on filgrastim
by: Caselli D, et al.
Published: (2016-02-01) -
Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia
by: Sevinç A, et al.
Published: (2018-01-01) -
Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia
by: Otremba B, et al.
Published: (2018-10-01) -
Two cases of clozapine induced thrombocytosis
by: N. Liyanage, et al.
Published: (2016-06-01)